BioCentury
ARTICLE | Clinical News

PA101: Phase II data

September 19, 2016 7:00 AM UTC

Top-line data from a double-blind, crossover, U.K. and Dutch Phase II trial in 24 IPF patients with refractory chronic cough showed that thrice-daily 40 mg inhaled PA101 delivered via the eFlow nebuli...